| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |